Bill > A04574

This bill modifies New York's cannabis law to expand the sale of cannabinoid hemp products with several key provisions. Starting January 1, 2026, licensed retailers will be permitted to sell any and all forms of cannabinoid hemp, provided the products meet certain requirements. The bill narrows the definition of THC (tetrahydrocannabinol) to specifically refer to Delta-9-THC and changes how total THC is calculated. It removes previous restrictions on certain forms of THC and simplifies the measurement of THC content. The legislation also mandates new labeling requirements for hemp-derived cannabinoid products, including a nutrition label, a warning that the product is not FDA-regulated or intended to treat medical conditions, the amount of hemp-derived product per serving in milligrams, and the manufacturer's address. Additionally, cannabinoid hemp flower products designed for smoking can only be sold to individuals 21 years and older. The bill directs the Office of Cannabis Management to repeal existing emergency regulations and gives the Cannabis Control Board authority to create safety rules for cannabinoid hemp, with the stipulation that these rules cannot prevent licensed hemp retailers from selling cannabinoid hemp products.

Business and Industry

https://www.nysenate.gov/legislation/bills/2025/A4574